Selected for the FY2022 'TOKYO Strategic Innovation Promotion Program'
Epistra Inc. has been selected for the “FY2023 TOKYO Strategic Innovation Promotion Program” administered by the Tokyo Metropolitan Small and Medium Enterprise Support Center.
This program is a subsidy initiative that supports small and medium-sized enterprises in Tokyo in developing innovative technologies and products based on their core technologies by leveraging external knowledge and expertise, in accordance with the “Innovation Map.”
Subsidy Details:
- Maximum Amount: 80 million yen over three years
- Eligible Expenses: Raw materials, machinery and equipment, outsourcing, expert consulting, personnel costs, certification and registration, exhibition participation, advertising, and more
Our company will continue to advance AI-driven R&D efficiency for our automated experiment optimization system “Epistra Accelerate” using Bayesian optimization technology.
Related Articles
Won Grand Prix in the 7th IP BASE AWARD Startup Category Hosted by the Japan Patent Office
On March 3, 2026, Epistra Inc. won the Grand Prix in the startup category at the '7th IP BASE AWARD' ceremony hosted by the Japan Patent Office.
Jikkenigaku Special Issue 'AI and Data-Driven Drug Discovery Research' Published — CTO Tsuzuki Authors Chapter on AI-Driven Drug Target Discovery
In 'Jikkenigaku Special Issue: AI and Data-Driven Drug Discovery Research' published by Yodosha, our CTO Taku Tsuzuki authored a chapter on AI-driven knowledge mining for drug target discovery.
Speaking Engagement: Delivered Keynote at the 10th Cell Manufacturing Kotozukuri Symposium
On March 4, 2026, CEO Yosuke Ozawa delivered a keynote speech on optimizing cell manufacturing processes using AI and robotics at the '10th Cell Manufacturing Kotozukuri Symposium' hosted by Osaka University.